In Re Certain Pharmaceuticals & Proceedings of Northland Providers, Inc.

78 F. Supp. 2d 954, 40 U.C.C. Rep. Serv. 2d (West) 1161, 1999 U.S. Dist. LEXIS 19257, 1999 WL 1144818
CourtDistrict Court, D. Minnesota
DecidedOctober 28, 1999
DocketMisc. 99-22 (DSD/RLE)
StatusPublished
Cited by3 cases

This text of 78 F. Supp. 2d 954 (In Re Certain Pharmaceuticals & Proceedings of Northland Providers, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Minnesota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re Certain Pharmaceuticals & Proceedings of Northland Providers, Inc., 78 F. Supp. 2d 954, 40 U.C.C. Rep. Serv. 2d (West) 1161, 1999 U.S. Dist. LEXIS 19257, 1999 WL 1144818 (mnd 1999).

Opinion

ORDER

DOTY, District Judge.

Based upon the Report and Recommendation of United States Magistrate Judge Raymond L. Erickson, and after an independent review of the files, records and proceedings in the above-titled matter, it is—

*956 ORDERED:

That D & K’s Motion for Return of Property [Docket No. 2] is granted, and the pharmaceuticals in question, and any proceeds from their Court-authorized sale, is to be distributed to D & K.

REPORT AND RECOMMENDATION

ERICKSON, United States Magistrate Judge.

At Duluth, in the District of Minnesota, this 5th day of October, 1999.

I. Introduction

This matter came before the undersigned United States Magistrate Judge pursuant to a general assignment, made in accordance with the provisions of Title 28 U.S.C. § 636(b)(1)(A), upon the Motion of D & K Healthcare Resources, Inc. (“D & K”), for the return of property, pursuant to Rule 41(e), Federal Rules of Criminal Procedure, that was seized during a federally warranted search.

Following the completion of several preliminary Hearings, an Evidentiary Hearing on the Motion was conducted on August 26, 1999, at which time, D & K appeared by Glenn E. Davis and Shawn W. Dunlevy, Esqs., and Cardinal Health (“Cardinal”), which has submitted a claim to the property in question, appeared by Janice M. Symchych, Esq. No appearances were made by Candi Creamer, or Lakeside Medical Supply, Inc. (“Lakeside”), whose previous claims to the property have been withdrawn. For reasons which follow, we recommend that the property at issue, and any proceeds from the prior sale or other disposition of that property, be distributed to D & K.

II. Procedural and Factual Background

The Government seized certain pharmaceuticals, which were in the possession of Lakeside, through the execution of Federal Search Warrants. Purportedly, the pharmaceuticals had been transferred to Lakeside from Northland Providers, Inc. (“Northland”). The pharmaceuticals were time-sensitive and, therefore, their medical and, a fortiori, their commercial worth, could have been rendered valueless if they were not promptly marketed. On the Record before us, the pharmaceuticals had been sold to Northland, and were subject to a perfected security interest, which had been executed by Northland in favor of D & K. As noted, neither Northland, nor Lakeside, opposed D & K’s Motion to recover the pharmaceuticals, or the proceeds from their sale, at the time of the Eviden-tiary Hearing.

Following our Order of June 3, 1999, which allowed D & K to sell the pharmaceuticals, so as to maximize their value prior to any expiration of their effective date, Cardinal filed a claim, on June 22, 1999, to any proceeds which would be recovered by that sale. According to Cardinal, the assets of Northland are subject to a Writ of Execution that was based upon a Judgment obtained by Cardinal against Northland. In addition, Cardinal argues that any funds, which were possessed by Lakeside, and which were owed to North-land, are subject to a Garnishment Summons which Cardinal has served upon Lakeside. Given the parties’ respective procedural postures, we recount the operative facts.

• D & K is a regional, wholesale distributor of pharmaceuticals which engaged in a series of transactions involving the sale of pharmaceuticals to Northland. See, D & K’s Verified Motion for Return of Property, at 1. Cardinal is a wholesale distributor of pharmaceuticals which also sold pharmaceuticals to Northland on account. See, Cardinal Health’s Hearing Memorandum, at 1. Lakeside is, purportedly, a Minnesota Corporation which is alleged to have received pharmaceuticals that are claimed to have been transferred from Northland. See, Cardinal Health’s Hearing Memorandum, at 2. Cardinal and D & K dispute several key aspects of the alleged transactions which resulted in Lakeside’s possession of the pharmaceuticals in question.

D & K contends that the transactions between Northland and Lakeside were not *957 sales in the “normal course of business” but, rather, were transactions that constitute an illegal diversion. See, D & K’s Verified Motion for Return of Property, at 4. D & K alleges that such a diversion may-well have been taken in order to remove the pharmaceuticals from the reach of D & K. The details of Lakeside’s incorporation are of little benefit in addressing the entitlement of D & K, or Cardinal, to the property in contest, as the documents evince Lakeside’s incorporation, under the laws of Minnesota, and little else. For example, the documents do nothing to illuminate how the pharmaceuticals were legally transferred — if, indeed they were— from Northland to Lakeside. They do suggest a close relationship, however, between the incorporators of Lakeside, and of Northland, which could have facilitated the type of illegal diversion to which D & K has alluded.

On or about February 26, 1999, the FBI executed a Search Warrant on Lakeside, and seized the pharmaceuticals which are the subject of this action. See, Cardinal Health’s Hearing Memorandum, at 2. The seizure was effected as a part of an investigation, by the United States Attorney for the District of Minnesota, into the activities of Northland, and associated individuals and entities. See, D & K’s Verified Motion for Return of Property, at 1. At the time that the Government took possession of the pharmaceuticals, Northland owed D & K in excess of $1,000,000 for prior pharmaceutical purchases. This debt was secured by an Inventory Purchase Money Security Agreement that is dated May 12, 1998. See, D & K’s Verified Motion for Return of Property, Attached Exhibit B . D & K perfected its security interest in Northland’s inventory by filing, on June 9, 1998, a Uniform Commercial Code Financing Statement with the Minnesota Secretary of State. See, D & K’s Verified Motion for Return of Property, Attached Exhibit C.

On March 5, 1999 — after the seizure of the drugs in question, and as a result of Northland’s inability to pay the debt owed by Northland to D & K, a Voluntary Surrender Agreement was executed by North-land in favor of D & K. See, D & K’s Verified Motion for Return of Property, Attached Exhibit E. This Surrender Agreement granted D & K the right to the immediate recovery of all inventory pledged to D & K as security by North-land, and all proceeds derived from the sale of D & K’s pharmaceuticals which were included in Northland’s inventory. Id.

D & K now contends that Lakeside may be the alter ego of Northland, which was formed for illegal purposes. See,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
78 F. Supp. 2d 954, 40 U.C.C. Rep. Serv. 2d (West) 1161, 1999 U.S. Dist. LEXIS 19257, 1999 WL 1144818, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-certain-pharmaceuticals-proceedings-of-northland-providers-inc-mnd-1999.